Jerre Stead was Executive Chairman and Chief Executive Officer of Clarivate plc from June 2019 until his retirement in October 2022. Mr. Stead served as CEO of Churchill Capital Corp until its merger with Clarivate in May 2019. During his career, Mr. Stead has served as CEO and/or Chair of ten public companies. Prior to…
Dr. Mervyn Turner has nearly 35 years of experience in pharmaceutical drug discovery, research and development, licensing and business development, emerging markets strategy development and implementation. He currently operates his own consulting firm, MJ Turner Consulting, where he counsels biotech, pharma, venture capital and investment banking firms. Dr. Turner spent 27 years at Merck & Co.…
Steve Young is an American Football Hall of Fame quarterback, a philanthropist, and a dedicated health advocate. In addition to his athletic achievements, Mr. Young has co-founded and serves as Managing Director at HGGC, a leading private equity firm, where he has gained extensive experience in business development and strategic growth. His advocacy work includes…
Dr. Stella Sarraf founded Spinogenix in 2016 to focus on developing novel neuroregenerative therapeutics. She brings a blend of large pharmaceutical operational expertise, venture investment background & entrepreneurship to Spinogenix. Dr. Sarraf is viewed as a visionary with a deep understanding of “cradle to grave” and the necessary components to achieve success from product concept…